[...] To view or add a comment, sign in Eli Lilly's VERVE-102, an investigational single-dose gene-editing medicine, shows groundbreaking potential as a one-time treatment for hypercholesterolemia by durably reducing LDL cholesterol by up to 62% and PCSK9 by up to 88% in the Phase 1b Heart-2 trial
She said she did a little bit of research on Google, but in the end still felt it was safer than sunbaking
Mourad, A., Straube, S., Armijo-Olivo, S
The British journal of nutrition 112 , 698708, doi:10.1017/S0007114514001378 (2014)
With consistent maintenance, many clients enjoy long-lasting, beautiful results that evolve naturally with their features over time
Skin feels stronger, more comfortable, and better protected